|
CA2621452A1
|
|
Stent and method for reducing tissue damage after ischemic injury with thymosin b4
|
|
US2008097581A1
|
|
Expandable medical device with beneficial agent concentration gradient
|
|
US2009252778A1
|
|
Methods and devices for reducing tissue damage after ischemic injury
|
|
US2008097589A1
|
|
Systems and methods for producing a medical device
|
|
EP1983930A2
|
|
Drug delivery system for retarding release of water soluble drugs
|
|
EP1948070A2
|
|
Methods and devices for reducing tissue damage after ischemic injury
|
|
US2007034528A1
|
|
Electropolishing apparatus and method for implantable medical devices
|
|
WO2006133223A2
|
|
Implantable medical device with openings for delivery of beneficial agents with combination release kinetics
|
|
US2006222679A1
|
|
System and method for loading a beneficial agent into a medical device
|
|
US2006177564A1
|
|
System and method for loading a beneficial agent into a medical device
|
|
US2006149354A1
|
|
Expandable medical device with improved spatial distribution
|
|
AU2005314565A1
|
|
Expandable medical device with differential hinge performance
|
|
AU2005262445A1
|
|
Expandable medical device for treating cardiac arrhythmias
|
|
US2006122697A1
|
|
Expandable medical device with openings for delivery of multiple beneficial agents
|
|
CA2805603A1
|
|
Bioresorbable stent with beneficial agent reservoirs
|
|
EP1997456A1
|
|
Drug coating device and method for wire filaments
|
|
AU2004203857A1
|
|
Expandable medical device for delivery of beneficial agent
|
|
US2005222676A1
|
|
Method and apparatus for loading a beneficial agent into an expandable medical device
|
|
AU2003287633A1
|
|
Method and apparatus for reducing tissue damage after ischemic injury
|
|
AU2001294634B2
|
|
Expandable medical device for delivery of beneficial agent
|
